Most often read
- •
This consensus brings together the most up-to-date information on rhinitis.
- •
Anamnesis is the key point in the suspected diagnosis and phenotype identification.
- •
It is especially important to recognize comorbidities.
- •
One aspect that impacts adequate treatment is low patient compliance.
- •
Hearing preservation in Cochlear Implant (CI) surgery should be encouraged.
- •
Even for patients with auditory nerve mutations, CI can still be recommended.
- •
Despite gene therapy in preliminary studies with OTOF gene, CI is still indicated.
- •
Patients with surgical wound infection should be evaluated and treated as quickly.
- •
Clinical and surgical approaches used for managing external auditory canal cholesteatoma.
- •
Non-surgical treatment effectively controlled 53.84% of external canal cholesteatomas.
- •
Advanced cases required canaloplasty, reconstruction, or mastoidectomy.
- •
95.83% of surgically treated patients showed no recurrence after follow-up.
- •
Stage II was most common, accounting for 63.5% of cases.
- •
CND and cCMV should be prioritized in the investigation of congenital SSD.
- •
CI is not recommended in children with SSD due to CND.
- •
CI is the most effective treatment for restoring hearing in SSD.
- •
Insufficient evidence to determine auditory deprivation duration for CI in SSD.
- •
Tympanomeatal flap advancement increases otomycosis risk by creating epithelial gaps.
- •
Adhered cerumen removal damages the epithelial barrier, raising otomycosis risk.
- •
Otomycosis does not impact tympanoplasty graft success.
- •
PBMT with steroids and training improved post-COVID olfaction, especially infrared.
- •
Infrared had a 68% response rate, surpassing red light (43.5%) and control (26.1%).
- •
PBMT with steroids and olfactory training was safe for treating smell disorders.
- •
Otosclerosis is linked to a high rate of Sensorineural Hearing Loss (SNHL).
- •
The prevalence of SNHL we found is higher than earlier reported.
- •
Many otosclerosis cases with sensorineural loss may go undiagnosed, hindering care.
- •
Our study offers insights to support further research in diagnosis and treatment.
- •
Transoral Robotic Surgery is well-established using the DaVinci system.
- •
Transoral robotic surgery with the Versius System is currently in its initial stage.
- •
A mannequin model was effective for training and setup configuration.
- •
The first human case demonstrated feasibility and excellent results.
- •
In our preliminary experience, Versius proved to be a promising robotic system.
- •
Adenoid hypertrophy is intrinsically related to OSA severity in obese children.
- •
DISE should be ideally recommended for children without adenotonsillar hypertrophy.
- •
The parameters in awake and DISE evaluations were equally related to OSA severity.
- •
Strong positive correlation between tumor thickness and tomographic depth of invasion.
- •
Positive correlation between tomographic tumor thickness and pathological tumor thickness.
- •
Positive correlation between tomographic depth of invasion and pathological depth of invasion.
- •
Tomographic evaluation of deep of invasion upstaged most of lesions.
- •
The most common complications were suture dehiscence and surgical site infections.
- •
Tumor thickness >10 mm increased risk of complications.
- •
Myocutaneous flap linked to higher complication rates.
- •
High mGPS scores predicted worse postoperative outcomes.
- •
Large mastoid cavity after CWD mastoidectomy should be obliterated properly.
- •
HA particles used for cavity obliteration should be properly covered.
- •
CGF promotes complete epithelialization of the mastoid cavity.
- •
The proportion of HPV-positive OPSCC in the Shanxi region has reached 58.8%.
- •
The status of lymph node metastasis has no significant impact on prognosis.
- •
P16 status does not affect the incidence of cervical lymph node metastasis.
- •
P16 positive reduces the risk of multiple lymph node metastases.
- •
Dupilumab tops for CRSwNP in network meta-analysis, reducing NPS and symptoms.
- •
Biologics exhibit comparable long-term safety to placebo.
- •
Personalized biologic choice crucial in CRSwNP; prolonged studies needed.
- •
Minimally invasive procedure of posterior nasal neurectomy.
- •
Accurate and cost-effective way to locate the sphenopalatine foramen.
- •
Quicker postoperative wound recovery and fewer surgical complications.
- •
Reduced mastoid volumes in microtia ears offer novel anatomical insights.
- •
Microtia ears show smaller mastoid height and area at specific levels.
- •
Data aids in preoperative counselling and technique selection.
- •
HRCT valuable for precise mastoid anatomy evaluation in microtia.
- •
Mastoid variations crucial for optimal microtia surgical outcomes.
- •
It is possible concluding that isotretinoin has potential aesthetic benefits.
- •
Studies have pointed towards improved skin appearance and nasal tip definition.
- •
However, these benefits may be more visible in the initial postoperative period.
- •
There are no protocols in the literature regarding dosage and duration of treatment.
- •
Induction therapy with TPF or TP has been indicated for advanced HNSCC patients.
- •
TPF is more toxic and requires infusion device or in-hospital administration of 5-FU.
- •
We analyzed the outcomes of advanced HNSCC patients treated with TPF or TP.
- •
ICT regimens did not alter patients’ toxicity, response rate and survival.
- •
TP is a good treatment option for advanced HNSCC in socioeconomically limited settings.
- •
Prolonged Acute Viral Rhinosinusitis is a cold lasting more than 7–10 days, with slow and progressive improvement, reinforcing its typically viral origin.
- •
Antibiotics should be used only in severe, unequivocally diagnosed ABRS. For moderated cases, the “watchful waiting/delayed prescription”, is recommended.
- •
Suspicion of orbital complication should be investigated with contrast CT and hospitalization under intravenous antibiotic therapy. Consider surgery.
- •
Surgery plays a very important role in the management of CRS. Either curative or providing control of the disease combined with medical treatment.
- •
Biologics are a good treatment option for some patients with severe CRSwNP refractory to standard treatment.
